ArticleFrontiers in pediatrics2026
Case Report: Allergic reaction following fecal microbiota transplantation in children with autism spectrum disorder: a report of two cases.
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Fecal microbiota transplantation (FMT) is increasingly used in children with autism spectrum disorder (ASD) and is generally considered to have an acceptable safety profile. However, the risk and mechanisms of severe adverse events in the high-risk subgroup of children with ASD complicated by multiple food intolerances (FI) have not been reported, and clinical strategies for risk prevention and management remain lacking. Case report: This article reports two cases of children with ASD and multiple FIs who developed anaphylactic shock following FMT, representing the first such report in the pediatric field. Case 1 presented with early-stage shock, which was considered to be associated with IgG-mediated type III hypersensitivity. Case 2 developed classic anaphylactic shock with a biphasic course characterized by relapse after initial resolution, raising the possibility of biphasic anaphylaxis. Both children improved after standardized anti-allergy and anti-shock treatment, and one child successfully completed subsequent FMT using a low-dose regimen. Conclusion: FMT carries a risk of anaphylactic shock in children with ASD and multiple FIs, who have underlying susceptibility due to impaired intestinal barrier function and immune dysregulation. Refined risk stratification, close monitoring throughout the procedure, individualized transplantation protocols, and standardized emergency procedures can effectively enhance the safety and feasibility of FMT in this high-risk subgroup.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.